NGM Biopharmaceuticals, Inc.
(NASDAQ:NGM)
$0.77
0.02 (2.95%)
Open: 3:59 PM
NGM Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
NGM Stock Price Today
NGM Biopharmaceuticals, Inc. (NGM) stock rallied over 5.40% intraday to trade at $0.7694 a share on NASDAQ. The stock opened with a gain of 12.00% at $0.84 and touched an intraday high of $0.85, rising 2.59% against the last close of $0.75. The NGM Biopharmaceuticals, Inc. in stock market went to a low of $0.76 during the session.
NGM Stock Snapshot
$0.75
Prev. Close
63.64 Million
Market Cap
$0.76
Day Low
$0.84
Open
N/A
Number of Shares
$0.85
Day High
N/A
P/E ratio
-1.84
EPS (TTM)
2.01
Cash Flow per Share
N/A
Free Float in %
2.05
Book Value
142966.00
Volume
NGM Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
333 Oyster Point BoulevardSouth San Francisco, CA 94080US
Website:https://www.ngmbio.com
Contact #:650 243 5555
Company Information
EmployeesN/A
Beta1.21
Sales or Revenue$22.43 Million
5Y Sales Change-3.86%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Peers
Frequently Asked Questions
What is the current NGM Biopharmaceuticals, Inc. (NGM) stock price?
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) stock price is $0.77 in the last trading session. During the trading session, NGM stock reached the peak price of $0.85 while $0.76 was the lowest point it dropped to. The percentage change in NGM stock occurred in the recent session was 5.40% while the dollar amount for the price change in NGM stock was $0.04.
NGM's industry and sector of operation?
The NASDAQ listed NGM is part of Biotechnology industry that operates in the broader Healthcare sector. NGM Biopharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer.
Who are the executives of NGM?
Mr. William J. Rieflin J.D.
Executive Chairman of Directors
Ms. Valerie L. Pierce J.D.
Senior Vice President, Gen. Counsel, Sec. & Chief Compliance Officer
Dr. David J. Woodhouse Ph.D.
Chief Executive Officer & Director
Mr. Brian Muma
Vice President of People Operations
How NGM did perform over past 52-week?
NGM's closing price is 0.35% higher than its 52-week low of $0.7611 where as its distance from 52-week high of $6.14 is -0.78%.
How many employees does NGM have?
Number of NGM employees currently stands at N/A. NGM operates from 333 Oyster Point Boulevard, South San Francisco, CA 94080, US.
Link for NGM official website?
Official Website of NGM is: https://www.ngmbio.com
How do I contact NGM?
NGM could be contacted at phone #650 243 5555 and can also be accessed through its website. NGM operates from 333 Oyster Point Boulevard, South San Francisco, CA 94080, US.
How many shares of NGM are traded daily?
NGM stock volume for the day was 142966.00 shares. The average number of NGM shares traded daily for last 3 months was 511.92 Thousands.
What is the market cap of NGM currently?
The market value of NGM currently stands at $63.64 Million with its latest stock price at $0.77 and N/A of its shares outstanding.